IB Acquisition raises $16M ahead of GNQ Insilico merger

What's the deal? IB Acquisition Corp.Dealroom has a profile for this one. Try Dealroom → raised $16,470,588 in a private placement tied to its pending merger with GNQ Insilico, Inc.Dealroom has a profile for this one. Try Dealroom →, according to a Form 8-K filed with the Securities and Exchange Commission on September 21, 2026. The agreements were entered on September 15, 2026.

Why now? The financing coincides with IB Acquisition's business combination with GNQ, the deal that will take GNQ public. Once the merger closes, the combined company's Class A common stock will trade on the Nasdaq Global Market under the symbol "GNQI."

What's the endgame? Alongside the placement, IB Acquisition secured an Equity Purchase Facility that lets it — but does not require it — sell up to $50 million in newly issued Class A common stock to an institutional investor. As consideration, the company will issue a convertible promissory note with a principal amount of $675,000.

The facility runs for up to 36 months from the date its initial resale registration statement is declared effective by the SEC. It carries a 4.99% beneficial ownership limit on the investor, which can rise to 9.99% on prior notice, and a 19.99% exchange cap unless stockholders approve otherwise.

What could go wrong? The company's ability to draw on the $50 million facility depends on the registration statement staying effective and other customary conditions. Purchase prices are tied to the volume weighted average price of the shares during each pricing period, so proceeds hinge on market performance after the merger closes.

The signal: The raise sits in a modest band for its category, landing in the bottom range of comparable deals by size. For IB Acquisition, the placement and standby facility together give the newly public GNQ a funding runway without committing to a single large offering upfront.

Image credit: Generated with Gemini